Sponsor Pipeline

Biohaven Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05337553 A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With… Spinal Muscular Atrophy Active, Not Recruiting
NCT03701399 Troriluzole in Adult Participants With Spinocerebellar Ataxia Spinocerebellar Ataxias Active, Not Recruiting
Disease Areas
Spinal Muscular Atrophy (1)
Get alerts when Biohaven Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free